This combination concurrently downregulates PD-L1 expression in tumor cells, decreases the levels of immunosuppressive cytokines such as IL-10 and TGF-β, elevates immunostimulatory IFN-γ, enhances the CTL response and boosts the memory response. This evidence concerns the gene CD274 and neoplasm.